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A novel splice variant of the DNA-PKcs gene is
associated with clinical and cellular radiosensitivity in
a patient with xeroderma pigmentosum
Fatemeh Abbaszadeh,1 Peter H Clingen,2 Colin F Arlett,3 Piers N Plowman,4
Emma C Bourton,1 Matthew Themis,5 Evgeny M Makarov,1 Robert F Newbold,1
Michael H L Green,6 Christopher N Parris1
ABSTRACT
Background Radiotherapy-induced DNA double-strand
breaks (DSBs) are critical cytotoxic lesions. Inherited
defects in DNA DSB repair pathways lead to
hypersensitivity to ionising radiation, immunodeficiency
and increased cancer incidence. A patient with
xeroderma pigmentosum complementation group C, with
a scalp angiosarcoma, exhibited dramatic clinical
radiosensitivity following radiotherapy, resulting in death.
A fibroblast cell line from non-affected skin
(XP14BRneo17) was hypersensitive to ionising radiation
and defective in DNA DSB repair.
Aim To determine the genetic defect causing cellular
radiation hypersensitivity in XP14BRneo17 cells.
Methods Functional genetic complementation whereby
copies of human chromosomes containing genes
involved in DNA DSB repair (chromosomes 2, 5, 8 10, 13
and 22) were individually transferred to XP14BRneo17
cells in an attempt to correct the radiation
hypersensitivity. Clonogenic survival assays and g-H2AX
immunofluorescence were conducted to measure
radiation sensitivity and repair of DNA DSBs. DNA
sequencing of defective DNA repair genes was
performed.
Results Transfer of chromosome 8 (location of DNA-
PKcs gene) and transfection of a mammalian expression
construct containing the DNA-PKcs cDNA restored
normal ionising radiation sensitivity and repair of DNA
DSBs in XP14BRneo17 cells. DNA sequencing of the
DNA-PKcs coding region revealed a 249-bp deletion
(between base pairs 3656 and 3904) encompassing
exon 31 of the gene.
Conclusion We provide evidence of a novel splice
variant of the DNA-PKcs gene associated with
radiosensitivity in a patient with xeroderma pigmentosum
and report the first double mutant in distinct DNA repair
pathways being consistent with viability.
INTRODUCTION
Anticancer radiotherapy (RT) protocols exert
cytotoxicity by inducing DNA damage, predomi-
nantly DNA double-strand breaks (DSBs). Human
cells possess enzymatic DNA repair systems which
monitor and repair such damage, and the efﬁcacy of
DNA repair has a signiﬁcant impact on the success
of RT1. In mammalian cells, two distinct
biochemical pathways are responsible for repairing
DSBs, homologous recombination and non-homol-
ogous end joining (NHEJ).2 NHEJ is the predomi-
nant repair pathway whereby the DNA-dependent
protein kinase heterodimer containing the
Ku80eKu70 complex binds to DNA ends and
recruits DNA-dependent protein kinase catalytic
subunit (DNA-PKcs) and its substrate, the Artemis
nuclease which prepares DNA ends for ligation.
Ligation is mediated by a protein complex
containing DNA ligase IV stabilised and stimulated
by XRCC4 and Cernunnos-XLF.3 Animal models
show that defects in any component of NHEJ can
lead to hypersensitivity to ionising radiation (IR),
genome instability, immunodeﬁciency and cancer.4
In humans, defects in the speciﬁc genetic compo-
nents of NHEJ also result in predisposition to
lymphoma and leukaemia or to extreme radiosen-
sitivity during RT.5 6
Xeroderma pigmentosum (XP) is a rare auto-
somal recessive disease characterised by sensitivity
to sunlight and susceptibility to skin cancers.7
There are seven XP complementation groups (AeG)
which deﬁne defects in nucleotide excision repair
(NER), responsible for excising UV-induced DNA
photodamage.8 Although cells from XP patients are
not typically sensitive to IR, cellular radiosensitivity
has been reported in ﬁbroblasts from an XPG
patient and in an XPC patient.9 10 The XPC patient
with a truncation in the C-terminus of the XPC
protein presented with an angiosarcoma of the
scalp, which was treated by surgical excision and
RT.11 Following 38 Gy in 19 fractions with 6 MeV
electrons, a severe scalp desquamation occurred
associated with necrosis of the underlying bone,
intracranial oedema and death.
A primary ﬁbroblast cell line (XP14BR) and an
SV40-transformed derivative cell line (XP14BRneo17)
from this patient were hypersensitive to the lethal
effects of IR and UV, consistent with the clinical
phenotype.11 Transfection with the XPC cDNA
restored a normal UV cytotoxic response, but IR
sensitivity was unchanged. XP14BR ﬁbroblasts were
distinguishable from radiosensitive ataxia telangiec-
tasia cells by virtue of a normal inhibition of DNA
synthesis after IR exposure. Repair of radiation-
induced DNA DSBs in XP14BR cells was signiﬁcantly
reduced compared with normal ﬁbroblast cell lines.11
XP14BR ﬁbroblasts were not sensitive to the lethal
effects of the DNA interstrand cross-linking agents,
mitomycin C or nitrogen mustard, indicating that
these cells were not defective in homologous recom-
bination, which plays an important role in regulating
interstrand cross-linking cytotoxicity.12
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In this paper we present evidence, from microcell-mediated
chromosome transfer (MMCT), expression plasmid transfer and
sequence analysis, that NHEJ was defective in this patient as
a result of a defect in the DNA-PKcs gene. The molecular basis of
this IR hypersensitivity is deletion of exon 31 of the DNA-PKcs
gene causing an in-frame deletion of 249 bp with a predicted 82-
amino acid deletion from the protein.
This is the second reported case of a defective DNA-PKcs gene
in human cells. It is also the ﬁrst reported case in which two
distinct DNA repair pathways (NER and NHEJ) are defective in
a single individual. These observations indicate how undiag-
nosed defects in DNA repair pathways leave patients at risk of
life-threatening toxicity during RT and imply the need for
a simple pretreatment screening protocol to identify individuals
at risk.
METHODS
Cell culture
The primary ﬁbroblast cell lines XP14BR, MRC5, NB1 and 1BR.3
and culture conditions are described in detail elsewhere.10 13 14
The SV40-immortalised ﬁbroblast cell lines XP14BRneo17,
1BR.3-G, MRC5-SV1 and GMO637 and culture conditions are all
described elsewhere.11 Culture of the MO59J human glioblas-
toma cell line used for western blot analysis has been previously
described.15
Clonogenic cell survival assays
Clonogenic cell survival assays after exposure to g-radiation (from
a
60
Cobalt source) were conducted as previously described.11 13
Microcell-mediated chromosome transfer
MMCT was performed as described elsewhere.16 Brieﬂy,
A9emonochromosome donor hybrids were exposed to
75e100 ng/ml colcemid (Sigma, Poole, Dorset, UK) for 48 h to
induce metaphase arrest and micronucleation. After a 5 min
incubation in serum-free medium containing 10 mg/ml cytocha-
lasin B (Sigma), micronuclei were harvested by centrifugation at
4500 rpm for 15 min at room temperature and puriﬁed by
successive ﬁltration through 8, 5 and 3 mm polycarbonate ﬁlters
(Whatman, Kent, UK). Puriﬁed micronuclei were fused to recip-
ient cells in the presence of 100 mg/ml phytohaemaglutinin B,
10% dimethyl sulfoxide and poly(ethylene glycol) (Sigma) for
1 min.Monochromosome hybrids of XP14BRneo17were selected
48 h later by incubating the cells in the presence of 150 mg/ml
hygromycin B (Merck Chemicals Ltd, Nottingham, UK). After
3 weeks, hygromycin B-resistant colonies were isolated.
g-Irradiation prescreen of XP14BRneo17 monochromosome
hybrids
To identify chromosomes that functionally correct the IR
hypersensitivity of XP14BRneo17 cells, hybrids were exposed to
2 Gy g-radiation. Five thousand cells were plated, and the
number of colonies formed after 3 weeks were expressed as
a percentage of colonies formed from non-g-irradiated cells.
Survival of XP14BRneo17 monochromosome hybrids at 2 Gy
was compared with that of XP14BRneo17 parental cells and the
repair normal cell line 1BR.3-G.
cDNA transfection
The cDNA expression constructs of DNA-PKcs and Ku80 were
a gift from Dr David Chen (Department of Radiation Oncology,
University of Texas Southwestern Medical Center, Dallas, Texas,
USA). The plasmid pCMPD-6 using the cytomegalovirus (CMV)
promoter contained a full-length human DNAePKcs cDNA. The
pKM-A1 plasmid (under control of the CMV promoter)
contained a full-length DNAePKcs cDNA with an inactivating
missense lysine-to-arginine mutation at amino acid 3752 in the
serine/threonine kinase domain of the protein.17 The Ku80 cDNA
was provided in the pIREShyg2 plasmid (BD Biosciences,
Cowley, Oxford, UK), with gene expression under the control of
the CMV promoter.
Transfection of XP14BRneo17 cells with the DNA-PKcs or
Ku80 expression plasmids was performed using calcium phos-
phate coprecipitation.17 The pCMPD-6 and pKM-A1 plasmids
with the DNA-PKcs cDNA were cotransfected with the pPur
plasmid (Clontech, Basingstoke, Hants, UK), conferring resis-
tance to the antibiotic, puromycin. Then 15 mg of each plasmid
was added to the cells for 24 h, after which cells were selected in
100 ng/ml puromycin for 4 weeks. For pIREShyg2-Ku80 plasmid
transfections, cells were selected in 150 units/ml hygromycin B.
Detection of g-H2AX foci: immunofluorescence assay
Nuclear g-H2AX foci after 2 Gy irradiation (at 0, 1, 5, 7, 9 and
24 h) were detected as described previously.18 Monoclonal anti-
body to phosphoserine139 g-H2AX (Millipore (U.K.) Limited,
Croxley Green Business Park, Watford, UK) at 1:10 000 dilution
was added for 1 h at room temperature. Alexa Fluor 488 goat anti-
mouse IgG antibody diluted 1:1000 was added to the cells for 1 h
(Molecular Probes, Paisley, UK), after which they were counter-
stained with 2 mg/ml propidium iodide in phosphate-buffered
saline and mounted in Vectashield (Vector Laboratories, Peter-
borough, UK). Analysis was performed by counting the number
of foci in a minimum of 100 nuclei of each cell line per time point
using a ﬂuorescence microscope. Results are expressed as the
percentage of g-H2AX-positive cells containing ﬁve or more g-
H2AX foci, as untreated cells typically exhibited 0e2 foci per/cell.
Western blot analysis
Protein extracts of XP14BR, MRC5, 1BR.3 primary human
ﬁbroblast and MO59J human glioblastoma cell line, derived from
23105 cells, were separated by sodium dodecyl sulfate/poly-
acrylamide gel electrophoresis using a 4e15% gradient gel (Bio-
Rad Laboratories Ltd, Hemel Hempstead, Herts, UK). Proteins of
interest were detected by western blotting using a mouse anti-
(human DNA-PKcs) monoclonal antibody (Lab Vision, Free-
mont, California, USA) or human b-actin as a loading control
(Abcam PLC, Cambridge, UK), and proteins were visualised by
chemiluminescence.
Figure 1 Clonogenic cell survival of XP14BRneo17 compared with
MRC5-SV1, GM0637 and 1BR.3-G after exposure to increasing doses of
g-radiation. The error bars represent the SEM response derived from
three independent experiments.
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DNA sequence analysis of the DNA-PKcs coding region
Total RNAwas isolated from primary XP14BR cells using TriZol
reagent (Sigma). cDNA was synthesised from total RNA using
random primers and Superscript III reverse transcriptase (InVi-
trogen). The DNA-PKcs cDNA sequence from XP14BR encom-
passing 12 291 bp was constructed in a contig of 17 fragments
between 800 and 1000 bp in size using gene-speciﬁc primers by
PCR. Each ampliﬁed fragment overlapped by w100 bp. cDNA
fragments were cloned into the pCR-4-Topo sequencing vector
(InVitrogen). Four individual clones of each fragment of DNA-
PKcs from XP14BR cells were subjected to DNA sequence
analysis on both the coding and non-coding strand.
RESULTS
The dose required to reduce clonogenic cell survival to 10% in
immortalised DNA repair normal cell lines, 1BR.3-G, MRC5-SV1
and GM0637, was 3.5, 4.8 and 4.8 Gy, respectively. For the
XP14BRneo17 cell line, 1.4 Gy reduced the clonogenic survival to
10% (ﬁgure 1). Hence XP14BRneo17 cells were 2.5e3.4-fold more
sensitive to the lethal effects of g-irradiation than the three
normal cell lines tested.
Normal copies of six individual human chromosomes
harbouring NHEJ genes required for DSB repair were individu-
ally transferred to XP14BRneo17 cells (table 1) and screened for
radiation sensitivity after exposure to 2 Gy g-irradiation (ﬁgure
2A). In all radiation-sensitive hybrids and in XP14BRneo17 cells,
the cell survival wasw10% or less. Transfer of chromosome 8 in
one hybrid (Chr.8 C) resulted in 46% cell survival, in line with the
level of cell survival expected in the repair normal cell line 1BR.3-
G. That only one hybrid containing chromosome 8 corrected the
radiation-sensitivity phenotype is consistent with previous
ﬁndings in which only a small proportion of hybrids exhibited
functional complementation.16 The prolonged colcemid expo-
sure during MMCT to induce micronucleation introduces small
intrachromosomal deletions in donor chromosomes, which often
encompass key loci, which, in these experiments, may include
the large DNA-PKcs genomic sequence (w200 kb). Complete
clonogenic survival assays showing a normal cell survival
response of hybrid Chr.8 C similar to the repair normal 1BR.3-G,
MRC5-SV1 and GM0637 cells are presented in ﬁgure 2B. As
chromosome 8 (8q11) contains the DNA-PKcs gene required for
NHEJ, this provided evidence that a mutation in DNA-PKcs may
account for the clinical and cellular radiosensitivity of this
patient.
XP14BRneo17 cells were transfected with an expression
plasmid containing the DNA-PKcs cDNA (pCMPD-6). As
Figure 2 A) Clonogenic cell survival after exposure to
2 Gy g-radiation of XP14BRneo17-monochromosome
hybrids, parental XP14BRneo17 cells and repair normal
1BR.3-G cells. The hybrid of chromosome 8 functionally
correcting the ionising radiation (IR) hypersensitivity of
XP14BRneo17 cells is indicated as Chr.8 C. (B)
Clonogenic cell survival of XP14BRneo17 compared with
MRC5-SV1, GM0637 and 1BR.3-G and hybrids of
XP14BRneo17 cells containing an additional human
chromosome 8, after exposure to increasing doses of g-
radiation. The chromosome 8 hybrid exhibiting
a corrected IR response is referred to as Chr.8 C. The
error bars represent the SEM response derived from
three independent experiments.
Table 1 Chromosomes containing genes involved in NHEJ together
with the number of hybrids derived from each MMCT experiment
Donor
cell line NHEJ repair gene
Number of
monochromosome
hybrids isolated
Number of
IR-resistant
hybrids (2 Gy)
A9-Chr.2 Ku80 and Cernunnos-XLF 7 0
A9-Chr.5 XRCC4 6 0
A9-Chr.8 DNA-PKcs 6 1
A9-Chr.10 Artemis 3 0
A9-Chr.13 Ligase IV 5 0
A9-Chr.22 Ku70 8 0
Chr, chromosome; NHEJ, non-homologous end joining; MMCT, microcell-mediated
chromosome transfer; IR, ionising radiation.
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a control, XP14BRneo cells were also transfected with an
expression plasmid containing a non-functional mutation in the
kinase domain of the DNA-PKcs cDNA (pPKM-A1). Figure 3A
shows that two clones of XP14BRneo17 transfected with
pCMPD-6 had a normal clonogenic cell survival response.
XP14BRneo17 cells transfected with the mutated DNA-PKcs
cDNA or the Ku80 cDNA remained radiation sensitive. Resto-
ration of a normal IR response by DNA-PKcs transfection in
Figure 3 (A) Clonogenic cell survival of XP14BRneo17
compared with MRC5-SV1, GM0637 and 1BR.3-G and
XP14BRneo17 cells after transfection with full-length
DNA-PKcs cDNA (pCMPD-6 clones 1 and 2) or DNA-PKcs
cDNA with a mutation in the kinase domain (pPKM-A1,
clones 1 and 2) and XP14BRneo17 cells transfected with
the Ku80 cDNA, after exposure to increasing doses of g-
radiation. The error bars represent the SEM response
derived from three independent experiments. (B) A
representative image of g-H2AX foci in the nuclei of
XP14BRneo 17 and a clone of XP14BR neo17 transfected
with the DNA-PKcs cDNA expression plasmid pCMPD-6
(clone 1) after exposure to 2 Gy g-irradiation. (C)
Induction and repair over a 24 h period of 2 Gy g-
radiation-induced g-H2AX foci in the nuclei of irradiated
cells. MRC5-SV1 and GMO637 are repair normal cell
lines. The ionising radiation (IR)-hypersensitive
XP14BRneo17 parental cell line is compared with
XP14BRneo17 cells transfected with either pCMPD-6
(normal DNA-PKcs) or pPKM-A1 (mutated DNA-PKcs)
and pIREShyg2-Ku80 (normal Ku80 cDNA). Error bars
represent the SEM of two independent experiments for
each cell line.
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XP14BRneo 17 cells was associated with efﬁcient DNA DSB
repair, measured by the induction and removal of g-H2AX foci in
the nuclei of cells irradiated with 2 Gy g-radiation. Representa-
tive examples of g-H2AX foci staining are shown in ﬁgure 3B.
Immediately after g-irradiation, over 80% of all cells had ﬁve or
more g-H2AX foci. Figure 3C shows that the normal level of
radiosensitivity exhibited by transfection of XP14BRneo17 cells
with the DNA-PKcs cDNA is associated with the removal of g-
H2AX foci similar to the normal ﬁbroblasts MRC5-SV1 and
GM0637. After 24 h, 65.5% of XP14BRneo17 cells retained ﬁve or
more g-H2AX foci. Also, in XP14BRneo17 cells transfected with
the mutated DNA-PKcs or the Ku80 cDNA, 70.11% and 76.20%,
respectively, of nuclei scored positive for g-H2AX foci after 24 h.
Two clones of XP14BRneo17 cells transfected with normal DNA-
PKcs showed a reduction of positive nuclei to 12.3% and 18.6%
after 24 h, which was similar to the normal MRC5-SV1 and
GMO636 cell lines.
We then investigated whether the DNA-PKcs protein was
produced in the XP14BR cells. DNA-PKcs protein expression
levels in XP14BR, MRC-5, 1BR.3 and MO59J cells detected by
western blot are shown in ﬁgure 4. In XP14BR cells, a protein
that comigrates with full-length DNA-PKcs protein is expressed
when compared with DNA repair normal MRC-5 and 1BR.3
cells. However, taking into account the mass of the DNA-PKcs
protein (470 kDa), it was not possible to detect small in-frame
deletions by western blotting. A band could not be detected in
the MO59J cells, consistent with a deletion of DNA-PKcs in this
repair-defective cell line.15
To identify the mutation, extensive DNA sequence analysis of
136 cloned fragments (four independent clones of each of the 17
fragments sequenced on the sense and antisense strand) of the
cDNA contig of DNA-PKcs of XP14BR revealed a 249 bp in-
frame deletion between base pairs 3656 and 3904 encompassing
the entire exon 31, resulting in a predicted 82-residue deletion.
This was observed in three of the four independent clones
sequenced. The location of this deletion within the context of the
DNA-PKcs coding sequence is shown in ﬁgure 5. To identify what
would cause the exon skipping, we sequenced the genomic DNA
surrounding exon 31. Sequencing of the surrounding intron/exon
junctions, including 250 bp intronic DNA either side of exon 31
in genomic DNA, did not reveal a splicing mutation. To conﬁrm
these observations, the cDNA encompassing this region was
sequenced from a second independent isolate of RNA from
XP14BR cells, and the exon 31 deletion was observed in two of
four clones. Sequence analysis of cDNA encompassing exons
30e32 of DNA-PKcs from two normal cell lines (1BR.3 and NB1:
four independent cloned fragments from each cell line) revealed
no such deletion.
DISCUSSION
In this study we report a primary defect in the DNA-PKcs gene
in normal (non-tumour) tissue from a human patient. DNA-
PKcs is an essential genetic component in the repair of ionising
radiation-induced DNA DSB via the NHEJ pathway The DNA-
PK complex consists of Ku70/80 heterodimer and a 470 kDa
catalytic subunit DNA-PKcs with serine/threonine kinase
activity. DNA-PKcs binds to DNA ends in a Ku80-dependent
manner, to initially suppress efﬁcient ligation of DNA ends.
DNA-PKcs autophosphorylation then liberates the DNA ends of
the strand break, allowing ligation by the ligase IVeXRCC4
protein complex. It is speculated that DNA-PKcs acts as
a molecular ‘gatekeeper ’ preventing premature ligation of DNA
ends.19
Animal models have shown that defects in any component of
NHEJ (including DNA-PKcs) can lead to hypersensitivity to IR,
genome instability, immunodeﬁciency and cancer.4 Until
recently, in humans, only two of these genes, ligase IV and
Artemis, have been linked to a predisposition for lymphoma or
leukaemia and to extreme radiosensitivity.5 6 The ﬁrst report that
mutations in the DNA-PKcs gene can result in radiosensitivity
and severe combined immunodeﬁciency involved a patient with
a missense mutation in the DNA-PKcs gene (L3062R) causing an
inability to activate Artemis leading to defective NHEJ.20
To deﬁne the molecular defect in DNA-PKcs in XP14BR cells,
western blot analysis (ﬁgure 4) indicated that a protein indis-
tinguishable in length from the DNA-PKcs protein was detect-
able when compared with the normal 1BR.3 and MRC5 cells.
These data suggested that it was unlikely that a large structural
deletion in the DNA-PKcs gene was responsible for the defective
function of the protein. DNA sequence analysis of the DNA-PKcs
cDNA in XP14BR revealed a 249 bp deletion of the entire exon 31
of the transcript, resulting in a predicted 82-amino acid deletion.
In two normal cell lines (1BR.3 andMRC5), exon 31 was retained
in the full-length transcript. Analysis of the intron/exon
boundaries of exon 31 did not reveal a splicing mutation.
There are two possibilities for why this splicing defect might
cause the radiosensitivity in XP14BR cells. Firstly, the patient is
heterozygous and therefore haploinsufﬁcient for the DNA-PKcs
protein; however, we did not identify any genomic mutation
causing the splicing abnormality in the DNA-PKcs coding
sequence. Secondly, we have identiﬁed a novel splicing isoform
of DNA-PKcs (EX31) which is expressed in the XP14BR patient,
and the EX31 protein is acting as a dominant-negative mutant.
The functional consequences of the predicted 82-amino acid
deletion from the protein are summarised in ﬁgure 5. Multiple
sequence alignments (http://www.ncbi.nlm.nih.gov/Structure/
cdd/cdd.shtml) and structural analysis (http://www.ics.uci.edu/
wbaldig/) indicate that the 82-amino acid sequence encoded by
exon 31 could be folded into an a-helix. Conservation of amino
acid residues between species indicates that the region may have
an important role in maintaining protein structure.
The deletion of an entire exon without an apparent splicing
mutation is not normally considered to be an unusual observa-
tion. For DNA-PKcs, at least three conserved splice variants,
including a full-length transcript (variant I), a transcript that
retains an intron between exon 82 and 83 (variant II), and
a transcript in which exon 80 is deleted (variant III), are
observed.21
Figure 4 (A) Western blot analysis of DNA-PKcs protein expression in
primary XP14BR compared with repair normal MRC-5 and 1BR.3 human
fibroblasts and DNA-PKcs defective MO59J human glioblastoma cell line.
(B) As a loading control, human b-actin expression in each cell type was
also examined.
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Pre-mRNA splicing is an essential step in the expression of
almost all eukaryotic genes, and alternative splicing appears to
be the mechanism responsible for the generation of up to 75% of
the human proteome. There are different modes of alternative
splicing; however, the differential inclusion or exclusion of an
exon or group of exons, so-called cassette exon, is the most
common type of alternative splicing event.22
In summary, we conclude that the deletion of exon 31 of the
DNA-PKcs gene in the XP14BR patient represents a novel
isoform of the DNA-PKcs gene whose expression is associated
with the clinical and cellular IR hypersensitivity. Interestingly,
immunodeﬁciency, often observed with human defects of NHEJ,
was not observed in this patient23. We provide only the second
reported case of an individual with a primary defect in the DNA-
PKcs gene, but the ﬁrst report of an individual with DNA repair
defects in two independent pathways, NHEJ and NER.
Finally, these data show how seemingly ‘mild’ or undiagnosed
defects in DNA repair factors, while consistent with viability, can
have catastrophic consequences should such an individual require
cytotoxic anticancer RT. Simple pretreatment screening proto-
cols such as measuring the induction of repair of nuclear g-H2AX
foci in patient cells,24 to identify individuals at risk, would
increase the safety of RT for such patients.
Funding The St Bartholomew’s and the London NHS Trust Charity.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1. Sekine I, Minna JD, Nishio K, Saijo N, Tamura T. Genes regulating the sensitivity of solid
tumor cell lines to cytotoxic agents: a literature review. Jpn J Clin Oncol 2007;37:329e36.
2. Scott SP, Pandita TK. The cellular control of DNA double-strand breaks. J Cell
Biochem 2006;99:1463e75.
3. Burma S, Chen BP, Chen DJ. Role of non-homologous end joining (NHEJ) in
maintaining genomic integrity. DNA Repair 2006;5:1042e8.
4. Bassing CH, Alt FW. The cellular response to general and programmed DNA double
strand breaks. DNA Repair 2004;3:781e96.
5. Riballo E, Critchlow SE, Teo SH, Doherty AJ, Priestley A, Broughton B, Kysela B, Beamish
H, Plowman N, Arlett CF, Lehmann AR, Jackson SP, Jeggo PA. Identification of a defect in
DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol 1999;9:699e702.
6. Musio A, Marrella V, Sobacchi C, Rucci F, Fariselli L, Giliani S, Lanzi G, Notarangelo
LD, Delia D, Colombo R, Vezzoni P, Villa A. Damaging-agent sensitivity of Artemis-
deficient cell lines. Eur J Immunol 2005;35:1250e6.
7. Kraemer KH, Lee MM, Scotto J. Xeroderma pigmentosum. Cutaneous, ocular, and
neurologic abnormalities in 830 published cases. Arch Dermatol 1987;123:241e50.
8. de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes.
Carcinogenesis 2000;21:453e60.
9. Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Ferguson-Smith MA, Morley WN.
Studies on a new case of xeroderma pigmentosum (XP3BR) from complementation
group G with cellular sensitivity to ionizing radiation. Carcinogenesis 1980;1:745e51.
10. Rogers PB, Plowman PN, Harris SJ, Arlett CF. Four radiation hypersensitivity cases
and their implications for clinical radiotherapy. Radiother Oncol 2000;57:143e54.
11. Arlett CF, Plowman PN, Rogers PB, Parris CN, Abbaszadeh F, Green MH, McMillan
TJ, Bush C, Foray N. Clinical and cellular ionizing radiation sensitivity in a patient with
xeroderma pigmentosum. Br J Radiol 2006;79:510e17.
12. Clingen PH, Arlett CF, Hartley JA, Parris CN. Chemosensitivity of primary human fibroblasts
with defective unhooking of DNA interstrand crosslinks. Exp Cell Res 2007;313:753e60.
13. Arlett CF, Harcourt SA. Survey of radiosensitivity in a variety of human cell strains.
Cancer Res 1980;40:926e32.
14. Boyle J, Kill IR, Parris CN. Heterogeneity of dimer excision in young and senescent
human dermal fibroblasts. Aging Cell 2005;4:247e55.
15. Anderson CW, Dunn JJ, Freimuth PI, Galloway AM, Allalunis-Turner MJ. Frameshift
mutation in PRKDC, the gene for DNA-PKcs, in the DNA repair-defective, human,
glioma-derived cell line MO59J. Radiat Res 2001;156:2e9.
16. Parris CN, Harris JD, Griffin DK, Cuthbert AP, Silver AJ, Newbold RF. Functional
evidence of novel tumor suppressor genes for cutaneous malignant melanoma.
Cancer Res 1999;59:516e20.
17. Kurimasa A, Kumano S, Boubnov NV, Story MD, Tung CS, Peterson SR, Chen DJ.
Requirement for the kinase activity of human DNA-dependent protein kinase catalytic
subunit in DNA strand break rejoining. Mol Cell Biol 1999;19:3877e84.
18. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonnert WM. DNA double-stranded breaks
induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858e68.
19. Uematsu N, Weterings E, Yano K, Morotomi-Yano K, Jakob B, Taucher-Scholz G,
Mari PO, van Gent DC, Chen BP, Chen DJ. Autophosphorylation of DNA-PKCS
regulates its dynamics at DNA double-strand breaks. J Cell Biol 2007;177:219e29.
20. van der Burg M, Ijspeert H, Verkaik NS, Turul T, Wiegant WW, Morotomi-Yano K,
Mari PO, Tezcan I, Chen DJ, Zdzienicka MZ, van Dongen JJ, van Gent DC. A DNA-PKcs
mutation in a radiosensitive T-B-SCID patient inhibits Artemis activation and non-
homologous end-joining. J Clin Invest 2009;119:91e8.
21. Convery E, Shin EK, Ding Q, Wang W, Douglas P, Davis LS, Nickoloff JA, Lees-Miller
SP, Meek K. Inhibition of homologous recombination by variants of the catalytic
subunit of the DNA-dependent protein kinase (DNA-PKcs). Proc Natl Acad Sci U S A
2005;102:1345e50.
22. Zavolan M, van Nimwegen E. The types and prevalence of alternative splice forms.
Curr Opin Structural Biol 2006;16:557.
23. Salob SP, Webb DKH, Atherton DJ. A child with xeroderma pigmentosum and bone
marrow failure. Br. J. Dermatol 1992;126:372e4.
24. Olive PL, Banath JP. Phosphorylation of histone H2AX as a measure of
radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys 2004;58:331e5.
Figure 5 Schematic view of the DNA-PKcs protein. Functional domains, identified from the Pfam database (http://pfam.sanger.ac.uk/), and the location
of exon 31 are highlighted. Comparisons with the DNA-PKcs protein sequences (NCBI) from other species from within the exon 31 region are shown in an
expanded view. Boxed sequences highlight evolutionarily conserved residues.
J Med Genet 2010;47:176e181. doi:10.1136/jmg.2009.068866 181
Original article
 group.bmj.com on April 13, 2010 - Published by jmg.bmj.comDownloaded from 
